Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJID (3) Autor Reis,Adriana O. (3) Cordeiro,Julio C. R. (2) Sader,Helio S. (2) Gales,Ana C. (1) Jones,Ronald N. (1) Machado,Antonia M.O. (1) Mendes,Rodrigo E. (1) Miranda,Eliete A. (1) Sader,Hélio S. (1) Mais... Palavra-chave Antimicrobial resistance (1) Antimicrobial resistance pattern (1) Antimicrobial susceptibility test (1) Arbekacin (1) Clonal dissemination (1) Linezolid (1) Nosocomial Infections (1) Nosocomial infection (1) ORSA (1) Oxacillin-resistant (1) Quality assurance (1) Quinupristin/dalfopristin-resistant Enterococcus faecium (1) Staphylococcus aureus (1) Vancomycin-resistant enterococci (1) Mais... Tipo do documento Info:eu-repo/semantics/article (3) Ano 2003 (1) 2001 (2) País Brazil (3) Idioma Inglês (3)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 3 Primeira ... 1 ... Última In vitro antimicrobial activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals BJID Reis,Adriana O.; Cordeiro,Julio C. R.; Machado,Antonia M.O.; Sader,Helio S.. The emergence of vancomycin-resistant enterococci (VRE) has been described recently in Brazil. This is in contrast to the USA and Europe, where the VRE appeared in the late 1980s. The progressive increase in VRE isolation poses important problems in the antimicrobial therapy of nosocomial infections. Treatment options and effective antimicrobial agents for VRE are often limited and the possibility of transfer of vancomycin genes to other Gram-positive microorganisms continues. In the search for antimicrobial agents for multiresistant Gram-positive cocci, compounds such as linezolid and quinupristin/dalfopristin have been evaluated. The present study was conducted to evaluate the in vitro activity of the oxazolidinone linezolid and 10 other antimicrobial... Tipo: Info:eu-repo/semantics/article Palavras-chave: Linezolid; Vancomycin-resistant enterococci; Quinupristin/dalfopristin-resistant Enterococcus faecium; Clonal dissemination; Nosocomial infection. Ano: 2001 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000500002 Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY antimicrobial surveillance program (1997-2000) BJID Mendes,Rodrigo E.; Reis,Adriana O.; Gales,Ana C.; Jones,Ronald N.; Sader,Hélio S.. The accuracy of antimicrobial susceptibility tests is a crucial step for the clinical management of patients with serious infections. They must be reliable and precise because they will guide antimicrobial therapy. Our main objective was to compare the results of susceptibility testing performed by the SENTRY coordinator laboratory with those reported by the participating Latin American medical centers. A total of 10,277 bacterial isolates were tested by the reference broth microdilution method at the coordinator laboratory in the United States. The tests were performed and interpreted following the National Committee for Clinical Laboratory Standards (NCCLS) recommendations. Ten antimicrobial agent-organism combinations were analyzed. The susceptibility... Tipo: Info:eu-repo/semantics/article Palavras-chave: Antimicrobial susceptibility test; Antimicrobial resistance pattern; Quality assurance. Ano: 2003 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702003000500001 In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals BJID Cordeiro,Julio C. R.; Reis,Adriana O.; Miranda,Eliete A.; Sader,Helio S.. Arbekacin is an aminoglycoside used in Japan for treating infections caused by gentamicin and oxacillin-resistant S. aureus (ORSA). The objective of this study was to determine the in vitro antimicrobial activity of arbekacin against 454 clinical isolates of ORSA. The isolates were consecutively collected between January and July, 2000, from patients hospitalized in 8 Brazilian medical centers. The antimicrobial susceptibility testing was performed by disk diffusion method according to NCCLS recommendations. The vast majority of the isolates, 453 strains (99.8%), were considered susceptible to arbekacin based on the criteria proposed by the Requirements for Antibiotic Products of Japan. Only 1 isolate (0.2%) was classified as resistant. On the other hand,... Tipo: Info:eu-repo/semantics/article Palavras-chave: Staphylococcus aureus; Arbekacin; Oxacillin-resistant; ORSA; Antimicrobial resistance; Nosocomial Infections. Ano: 2001 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000300005 Registros recuperados: 3 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco